Over 10,000 results
Page 27 of 100
424B5
rkbgov5yj5ym1m o1
2 Jul 24
Prospectus supplement for primary offering
11:04am
424B2
4l0qbthdqlrxev 88g
2 Jul 24
Prospectus for primary offering
10:21am
424B2
f6650a
2 Jul 24
Prospectus for primary offering
10:18am
424B2
7v9j4 lo8k0wogdcqf7w
2 Jul 24
Prospectus for primary offering
10:13am
424B2
3bqjwd1s9z6db76w7
2 Jul 24
Prospectus for primary offering
10:06am
424B4
dwgtfbkxcuwfic
2 Jul 24
Prospectus supplement with pricing info
10:01am
424B2
ve93lkveg 2y8xd1jq
2 Jul 24
Prospectus for primary offering
9:54am
424B2
8pk3asqq 7guh
2 Jul 24
Prospectus for primary offering
9:52am
8-K
EX-99.1
4gvaiy rq
2 Jul 24
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
9:29am
8-K
EX-99.1
zjxsw21j
2 Jul 24
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
9:28am
8-K
EX-99.1
90i663sjdj 3tzm
2 Jul 24
Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing
9:16am
SC TO-T/A
EX-99
8zfw19bhuxxxle
2 Jul 24
Third party tender offer statement (amended)
9:16am
424B2
7muftgsbgfv1q
2 Jul 24
Prospectus for primary offering
9:09am
SC TO-I/A
pje987 t40j3pe38ic
2 Jul 24
Issuer tender offer statement (amended)
9:06am
424B2
0s5t7yii
2 Jul 24
Prospectus for primary offering
9:05am
DEFA14A
5s5lnn4na4xyb2aa
2 Jul 24
Additional proxy soliciting materials
9:00am
8-K
EX-99.1
ccr47a1n08grfl
2 Jul 24
Regulation FD Disclosure
8:44am
NT 10-K
94s5n wv9jjg1g2w
2 Jul 24
Notice of late annual filing
8:38am